We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$16.7M
Cap. Flow
-$84.9M
Cap. Flow %
-4.82%
Top 10 Hldgs %
24.37%
Holding
275
New
15
Increased
54
Reduced
181
Closed
13

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$12.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.2M
3
DOCS icon
Doximity
DOCS
+$8.19M
4
ESTA icon
Establishment Labs
ESTA
+$6.27M
5
COLB icon
Columbia Banking Systems
COLB
+$5M

Top Sells

Rank Stock Value
1
IAA
IAA, Inc. Common Stock
IAA
+$17.7M
2
MED icon
Medifast
MED
+$17.2M
3
ALBO
Albireo Pharma Inc
ALBO
+$11.1M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$6.11M
5
WNS
WNS Holdings
WNS
+$5.97M

Sector Composition

Rank Sector Weight
1 Healthcare 27.26%
2 Technology 26.93%
3 Industrials 17.12%
4 Consumer Discretionary 9.62%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENSG icon
126
The Ensign Group
ENSG
$10.7B
$3.5M 0.2%
36,592
-447
-1% -$41K
QNST icon
127
QuinStreet
QNST
$1.26B
$3.49M 0.2%
219,941
-4,211
-2% -$66.6K
LUNA
128
DELISTED
Luna Innovations Incorporated
LUNA
$3.48M 0.2%
483,370
-9,428
-2% -$83.2K
CBZ icon
129
CBIZ
CBZ
$2.95B
$3.46M 0.2%
69,847
-1,469
-2% -$70.8K
TBRG
130
DELISTED
TruBridge
TBRG
$3.45M 0.2%
114,163
+30,771
+37% +$896K
MTRN icon
131
Materion
MTRN
$5.83B
$3.39M 0.19%
29,189
-13,917
-32% -$1.4M
BMRN icon
132
BioMarin Pharmaceuticals
BMRN
$13.3B
$3.31M 0.19%
34,039
-369
-1% -$38.3K
KRTX
133
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$3.31M 0.19%
+18,199
New +$3.48M
USPH icon
134
US Physical Therapy
USPH
$1.24B
$3.26M 0.19%
33,268
-515
-2% -$49.1K
XPEL icon
135
XPEL
XPEL
$1.31B
$3.21M 0.18%
47,267
-761
-2% -$53.7K
PRFT
136
DELISTED
Perficient Inc
PRFT
$3.21M 0.18%
44,420
-813
-2% -$59.4K
HURN icon
137
Huron Consulting
HURN
$2.42B
$3.15M 0.18%
39,188
-30,249
-44% -$2.2M
PZZA icon
138
Papa John's
PZZA
$785M
$3.14M 0.18%
41,925
-432
-1% -$36.6K
VICR icon
139
Vicor
VICR
$9.63B
$3.06M 0.17%
65,253
-897
-1% -$49.8K
ONT
140
Onterris Inc
ONT
$546M
$3.06M 0.17%
85,854
-1,673
-2% -$75.7K
IRD
141
Opus Genetics
IRD
$302M
$3.03M 0.17%
809,117
+3,050
+0.4% +$11K
TFX icon
142
Teleflex
TFX
$5.89B
$3.03M 0.17%
11,956
+304
+3% +$73.7K
ICLR icon
143
Icon
ICLR
$12.8B
$3.02M 0.17%
14,146
-155
-1% -$34.5K
ADTN icon
144
Adtran
ADTN
$622M
$2.95M 0.17%
185,958
-3,880
-2% -$67.3K
NEOG icon
145
Neogen
NEOG
$2.49B
$2.94M 0.17%
+158,752
New +$2.98M
WKME
146
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
$2.94M 0.17%
276,294
+63,346
+30% +$645K
HAYN
147
DELISTED
Haynes International, Inc.
HAYN
$2.93M 0.17%
58,563
-1,126
-2% -$59.2K
ABST
148
DELISTED
Absolute Software Corp
ABST
$2.89M 0.16%
369,366
-7,362
-2% -$71.9K
BOOM icon
149
DMC Global
BOOM
$153M
$2.84M 0.16%
129,446
-1,382
-1% -$31.6K
IRMD icon
150
iRadimed
IRMD
$1.15B
$2.84M 0.16%
72,271
-967
-1% -$35.1K
4 5
6
7 8

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Rice Hall James & Associates held 275 positions worth $1.76B, up 0.96% from $1.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $84.9M in Q1 2023, closing 13 positions and reducing 181 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in RB Global worth $11.7M.

  • Rice Hall James & Associates's largest Q1 2023 buy was RB Global: 207,333 shares worth $11.7M.
  • Rice Hall James & Associates added most to Pacira BioSciences in Q1 2023, an estimated $12.2M increase.
  • Rice Hall James & Associates's biggest Q1 2023 reduction was Medifast, cutting an estimated $17.2M.
  • Rice Hall James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $17.7M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.76B portfolio in Q1 2023.
  • Rice Hall James & Associates opened 15 new positions and closed 13 in Q1 2023.
  • Rice Hall James & Associates's portfolio value rose 0.96% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q1 2023, filed 12 May 2023.